Strategies to Reduce Oxidative Stress in Glaucoma Patients

Background: Primary open-angle glaucoma (POAG) is a multifactorial pathology involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is the consequence of the imbalance between excessive formation and insufficient protection against reactive oxygen/nitrogen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current neuropharmacology 2018-01, Vol.16 (7), p.903-918
Hauptverfasser: Pinazo-Duran, Maria D, Shoaie-Nia, Kian, Zanon-Moreno, Vicente, Sanz-Gonzalez, Silva M, Del Castillo, Javier Benitez, Garcia-Medina, Jose J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 918
container_issue 7
container_start_page 903
container_title Current neuropharmacology
container_volume 16
creator Pinazo-Duran, Maria D
Shoaie-Nia, Kian
Zanon-Moreno, Vicente
Sanz-Gonzalez, Silva M
Del Castillo, Javier Benitez
Garcia-Medina, Jose J
description Background: Primary open-angle glaucoma (POAG) is a multifactorial pathology involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is the consequence of the imbalance between excessive formation and insufficient protection against reactive oxygen/nitrogen species. Objective: Our main goal is to gather molecular information to better managing pathologic variants that may determine the individual susceptibility to oxidative/nitrosative stress (OS/NS) and POAG. Method: An extensive search of the scientific literature was conducted using PUBMED, the Web of Science, the Cochrane Library, and other references on the topic of POAG and OS/NS from human and animal model studies published between 2010 and 2017. Finally, 152 works containing relevant information that may help understanding the role of antioxidants, essential fatty acids, natural compounds and other similar strategies for counteracting OS/NS in POAG were considered. Results: A wide variety of studies have proven that antioxidants, among them vitamins B3, C and E, Coenzyme Q10 or melatonin, ω-3/ω-6 fatty acids and other natural compounds (such as coffee, green tea, bear bile, gingko biloba, coleus, tropical fruits, etc.,) may help regulating the intraocular pressure as well as protecting the retinal neurons against OS/NS in POAG. Conclusion: Based on the impact of antioxidants and ω-3/ω-6 fatty acids at the molecular level in the glaucomatous anterior and posterior eye segments, further studies are needed by integrating all issues involved in glaucoma pathogenesis, endogenous and exogenous risk factors and their interactions that will allow us to reach newer effective biotherapies for preventing glaucomatous irreversible blindness.
doi_str_mv 10.2174/1570159X15666170705101910
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6120109</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2188099713</sourcerecordid><originalsourceid>FETCH-LOGICAL-b632t-34fe36b0cfad3b989d29143e9591496acdb40365aaca1022d764f7dcddeae3753</originalsourceid><addsrcrecordid>eNp1kEuP1DAQhCMEYh_wF1AQ54Dbju2YAxJawS7SSot4SNxajt2ZyZJJgu3MwJ0fjodZRnDg1C3VV92lKoqnwJ5z0PULkJqBNF9AKqVAM80kMDDA7hWn0GhZKTDsft4zV-3Bk-IsxlvGuGy4flic8EZpXRt5Wrz8mIJNtOoplmkqP5BfHJU333tvU7-lMssUY9mP5eVgFzdtbPk-KzSm-Kh40Nkh0uO7eV58fvvm08VVdX1z-e7i9XXVKsFTJeqOhGqZ66wXrWmM5wZqQUbmYZR1vq2ZUNJaZ4Fx7rWqO-2d92RJaCnOi1eHu_PSbsi7_DvYAefQb2z4gZPt8V9l7Ne4mraogDNgJh94dncgTN8WiglvpyWMOTNyaBpmjAaRKXOgXJhiDNQdPwDDfe3439qz98nfEY_OPz1n4OcBaHPGtd1Elyt0dATXKc242-2QlkBfbaSBXMJcN04zjUsY8j6m7MV5PeOKxkBoQ-rdQNjHOP7OhvtwuJ2GZUMIai8shBrjbFeEhgnxCwa1seY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2188099713</pqid></control><display><type>article</type><title>Strategies to Reduce Oxidative Stress in Glaucoma Patients</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Pinazo-Duran, Maria D ; Shoaie-Nia, Kian ; Zanon-Moreno, Vicente ; Sanz-Gonzalez, Silva M ; Del Castillo, Javier Benitez ; Garcia-Medina, Jose J</creator><creatorcontrib>Pinazo-Duran, Maria D ; Shoaie-Nia, Kian ; Zanon-Moreno, Vicente ; Sanz-Gonzalez, Silva M ; Del Castillo, Javier Benitez ; Garcia-Medina, Jose J</creatorcontrib><description>Background: Primary open-angle glaucoma (POAG) is a multifactorial pathology involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is the consequence of the imbalance between excessive formation and insufficient protection against reactive oxygen/nitrogen species. Objective: Our main goal is to gather molecular information to better managing pathologic variants that may determine the individual susceptibility to oxidative/nitrosative stress (OS/NS) and POAG. Method: An extensive search of the scientific literature was conducted using PUBMED, the Web of Science, the Cochrane Library, and other references on the topic of POAG and OS/NS from human and animal model studies published between 2010 and 2017. Finally, 152 works containing relevant information that may help understanding the role of antioxidants, essential fatty acids, natural compounds and other similar strategies for counteracting OS/NS in POAG were considered. Results: A wide variety of studies have proven that antioxidants, among them vitamins B3, C and E, Coenzyme Q10 or melatonin, ω-3/ω-6 fatty acids and other natural compounds (such as coffee, green tea, bear bile, gingko biloba, coleus, tropical fruits, etc.,) may help regulating the intraocular pressure as well as protecting the retinal neurons against OS/NS in POAG. Conclusion: Based on the impact of antioxidants and ω-3/ω-6 fatty acids at the molecular level in the glaucomatous anterior and posterior eye segments, further studies are needed by integrating all issues involved in glaucoma pathogenesis, endogenous and exogenous risk factors and their interactions that will allow us to reach newer effective biotherapies for preventing glaucomatous irreversible blindness.</description><identifier>ISSN: 1570-159X</identifier><identifier>EISSN: 1875-6190</identifier><identifier>DOI: 10.2174/1570159X15666170705101910</identifier><identifier>PMID: 28677495</identifier><language>eng</language><publisher>United Arab Emirates: Bentham Science Publishers Ltd</publisher><subject>Animal models ; Animals ; Antioxidants ; Antioxidants - therapeutic use ; Bile ; Blindness ; Coenzyme Q10 ; Coffee ; Fatty acids ; Glaucoma ; Glaucoma - drug therapy ; Glaucoma - metabolism ; Green tea ; Humans ; Melatonin ; Oxidative stress ; Oxidative Stress - drug effects ; Oxidative Stress - physiology ; Reactive nitrogen species ; Reactive oxygen species ; Retina ; Risk factors ; Vitamins</subject><ispartof>Current neuropharmacology, 2018-01, Vol.16 (7), p.903-918</ispartof><rights>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.</rights><rights>Copyright Bentham Science Aug 2018</rights><rights>2018 Bentham Science Publishers 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b632t-34fe36b0cfad3b989d29143e9591496acdb40365aaca1022d764f7dcddeae3753</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120109/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120109/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28677495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pinazo-Duran, Maria D</creatorcontrib><creatorcontrib>Shoaie-Nia, Kian</creatorcontrib><creatorcontrib>Zanon-Moreno, Vicente</creatorcontrib><creatorcontrib>Sanz-Gonzalez, Silva M</creatorcontrib><creatorcontrib>Del Castillo, Javier Benitez</creatorcontrib><creatorcontrib>Garcia-Medina, Jose J</creatorcontrib><title>Strategies to Reduce Oxidative Stress in Glaucoma Patients</title><title>Current neuropharmacology</title><addtitle>CN</addtitle><description>Background: Primary open-angle glaucoma (POAG) is a multifactorial pathology involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is the consequence of the imbalance between excessive formation and insufficient protection against reactive oxygen/nitrogen species. Objective: Our main goal is to gather molecular information to better managing pathologic variants that may determine the individual susceptibility to oxidative/nitrosative stress (OS/NS) and POAG. Method: An extensive search of the scientific literature was conducted using PUBMED, the Web of Science, the Cochrane Library, and other references on the topic of POAG and OS/NS from human and animal model studies published between 2010 and 2017. Finally, 152 works containing relevant information that may help understanding the role of antioxidants, essential fatty acids, natural compounds and other similar strategies for counteracting OS/NS in POAG were considered. Results: A wide variety of studies have proven that antioxidants, among them vitamins B3, C and E, Coenzyme Q10 or melatonin, ω-3/ω-6 fatty acids and other natural compounds (such as coffee, green tea, bear bile, gingko biloba, coleus, tropical fruits, etc.,) may help regulating the intraocular pressure as well as protecting the retinal neurons against OS/NS in POAG. Conclusion: Based on the impact of antioxidants and ω-3/ω-6 fatty acids at the molecular level in the glaucomatous anterior and posterior eye segments, further studies are needed by integrating all issues involved in glaucoma pathogenesis, endogenous and exogenous risk factors and their interactions that will allow us to reach newer effective biotherapies for preventing glaucomatous irreversible blindness.</description><subject>Animal models</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Antioxidants - therapeutic use</subject><subject>Bile</subject><subject>Blindness</subject><subject>Coenzyme Q10</subject><subject>Coffee</subject><subject>Fatty acids</subject><subject>Glaucoma</subject><subject>Glaucoma - drug therapy</subject><subject>Glaucoma - metabolism</subject><subject>Green tea</subject><subject>Humans</subject><subject>Melatonin</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - physiology</subject><subject>Reactive nitrogen species</subject><subject>Reactive oxygen species</subject><subject>Retina</subject><subject>Risk factors</subject><subject>Vitamins</subject><issn>1570-159X</issn><issn>1875-6190</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEuP1DAQhCMEYh_wF1AQ54Dbju2YAxJawS7SSot4SNxajt2ZyZJJgu3MwJ0fjodZRnDg1C3VV92lKoqnwJ5z0PULkJqBNF9AKqVAM80kMDDA7hWn0GhZKTDsft4zV-3Bk-IsxlvGuGy4flic8EZpXRt5Wrz8mIJNtOoplmkqP5BfHJU333tvU7-lMssUY9mP5eVgFzdtbPk-KzSm-Kh40Nkh0uO7eV58fvvm08VVdX1z-e7i9XXVKsFTJeqOhGqZ66wXrWmM5wZqQUbmYZR1vq2ZUNJaZ4Fx7rWqO-2d92RJaCnOi1eHu_PSbsi7_DvYAefQb2z4gZPt8V9l7Ne4mraogDNgJh94dncgTN8WiglvpyWMOTNyaBpmjAaRKXOgXJhiDNQdPwDDfe3439qz98nfEY_OPz1n4OcBaHPGtd1Elyt0dATXKc242-2QlkBfbaSBXMJcN04zjUsY8j6m7MV5PeOKxkBoQ-rdQNjHOP7OhvtwuJ2GZUMIai8shBrjbFeEhgnxCwa1seY</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Pinazo-Duran, Maria D</creator><creator>Shoaie-Nia, Kian</creator><creator>Zanon-Moreno, Vicente</creator><creator>Sanz-Gonzalez, Silva M</creator><creator>Del Castillo, Javier Benitez</creator><creator>Garcia-Medina, Jose J</creator><general>Bentham Science Publishers Ltd</general><general>Benham Science Publishers</general><general>Bentham Science Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20180101</creationdate><title>Strategies to Reduce Oxidative Stress in Glaucoma Patients</title><author>Pinazo-Duran, Maria D ; Shoaie-Nia, Kian ; Zanon-Moreno, Vicente ; Sanz-Gonzalez, Silva M ; Del Castillo, Javier Benitez ; Garcia-Medina, Jose J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b632t-34fe36b0cfad3b989d29143e9591496acdb40365aaca1022d764f7dcddeae3753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Antioxidants - therapeutic use</topic><topic>Bile</topic><topic>Blindness</topic><topic>Coenzyme Q10</topic><topic>Coffee</topic><topic>Fatty acids</topic><topic>Glaucoma</topic><topic>Glaucoma - drug therapy</topic><topic>Glaucoma - metabolism</topic><topic>Green tea</topic><topic>Humans</topic><topic>Melatonin</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - physiology</topic><topic>Reactive nitrogen species</topic><topic>Reactive oxygen species</topic><topic>Retina</topic><topic>Risk factors</topic><topic>Vitamins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pinazo-Duran, Maria D</creatorcontrib><creatorcontrib>Shoaie-Nia, Kian</creatorcontrib><creatorcontrib>Zanon-Moreno, Vicente</creatorcontrib><creatorcontrib>Sanz-Gonzalez, Silva M</creatorcontrib><creatorcontrib>Del Castillo, Javier Benitez</creatorcontrib><creatorcontrib>Garcia-Medina, Jose J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pinazo-Duran, Maria D</au><au>Shoaie-Nia, Kian</au><au>Zanon-Moreno, Vicente</au><au>Sanz-Gonzalez, Silva M</au><au>Del Castillo, Javier Benitez</au><au>Garcia-Medina, Jose J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Strategies to Reduce Oxidative Stress in Glaucoma Patients</atitle><jtitle>Current neuropharmacology</jtitle><addtitle>CN</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>16</volume><issue>7</issue><spage>903</spage><epage>918</epage><pages>903-918</pages><issn>1570-159X</issn><eissn>1875-6190</eissn><abstract>Background: Primary open-angle glaucoma (POAG) is a multifactorial pathology involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is the consequence of the imbalance between excessive formation and insufficient protection against reactive oxygen/nitrogen species. Objective: Our main goal is to gather molecular information to better managing pathologic variants that may determine the individual susceptibility to oxidative/nitrosative stress (OS/NS) and POAG. Method: An extensive search of the scientific literature was conducted using PUBMED, the Web of Science, the Cochrane Library, and other references on the topic of POAG and OS/NS from human and animal model studies published between 2010 and 2017. Finally, 152 works containing relevant information that may help understanding the role of antioxidants, essential fatty acids, natural compounds and other similar strategies for counteracting OS/NS in POAG were considered. Results: A wide variety of studies have proven that antioxidants, among them vitamins B3, C and E, Coenzyme Q10 or melatonin, ω-3/ω-6 fatty acids and other natural compounds (such as coffee, green tea, bear bile, gingko biloba, coleus, tropical fruits, etc.,) may help regulating the intraocular pressure as well as protecting the retinal neurons against OS/NS in POAG. Conclusion: Based on the impact of antioxidants and ω-3/ω-6 fatty acids at the molecular level in the glaucomatous anterior and posterior eye segments, further studies are needed by integrating all issues involved in glaucoma pathogenesis, endogenous and exogenous risk factors and their interactions that will allow us to reach newer effective biotherapies for preventing glaucomatous irreversible blindness.</abstract><cop>United Arab Emirates</cop><pub>Bentham Science Publishers Ltd</pub><pmid>28677495</pmid><doi>10.2174/1570159X15666170705101910</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1570-159X
ispartof Current neuropharmacology, 2018-01, Vol.16 (7), p.903-918
issn 1570-159X
1875-6190
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6120109
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Animal models
Animals
Antioxidants
Antioxidants - therapeutic use
Bile
Blindness
Coenzyme Q10
Coffee
Fatty acids
Glaucoma
Glaucoma - drug therapy
Glaucoma - metabolism
Green tea
Humans
Melatonin
Oxidative stress
Oxidative Stress - drug effects
Oxidative Stress - physiology
Reactive nitrogen species
Reactive oxygen species
Retina
Risk factors
Vitamins
title Strategies to Reduce Oxidative Stress in Glaucoma Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T19%3A27%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Strategies%20to%20Reduce%20Oxidative%20Stress%20in%20Glaucoma%20Patients&rft.jtitle=Current%20neuropharmacology&rft.au=Pinazo-Duran,%20Maria%20D&rft.date=2018-01-01&rft.volume=16&rft.issue=7&rft.spage=903&rft.epage=918&rft.pages=903-918&rft.issn=1570-159X&rft.eissn=1875-6190&rft_id=info:doi/10.2174/1570159X15666170705101910&rft_dat=%3Cproquest_pubme%3E2188099713%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2188099713&rft_id=info:pmid/28677495&rfr_iscdi=true